Max Hodak’s TechCrunch Disrupt appearance Former Neuralink president and co‑founder Max Hodak addressed the audience at this year’s TechCrunch Disrupt conference. In his presentation, Hodak outlined how his current company is working with a partner called PRIMA to advance a novel brain‑computer interface (BCI) platform.
The PRIMA collaboration While details of the partnership remain limited, Hodak emphasized that the work with PRIMA is a strategic component of a broader development roadmap. He described the effort as a building block toward a next‑generation BCI that could eventually enable more seamless interaction between the human brain and digital devices.
Why the announcement matters Neuralink’s high‑profile experiments have kept BCI technology in the public eye. Hodak’s remarks suggest that other entrepreneurs are pursuing parallel pathways, potentially diversifying the technological approaches and market dynamics within the sector. By positioning the PRIMA work as part of a longer‑term plan, Hodak signaled that the industry may see incremental milestones before any commercial product emerges.
Looking ahead The presentation did not include a timeline for a prototype or commercial release. However, Hodak indicated that future updates will be shared as the collaboration progresses. Stakeholders will likely watch for technical disclosures, regulatory filings, or demonstration events that could provide clearer insight into the viability of the proposed BCI.
Industry context Brain‑computer interfaces aim to translate neural activity into digital commands, a field that spans medical therapeutics, assistive technology, and consumer applications. While Neuralink remains the most visible player, emerging ventures like Hodak’s underscore a growing ecosystem of innovators seeking to overcome technical and regulatory hurdles.
--- *The information presented is based on Max Hodak’s remarks at TechCrunch Disrupt and publicly known background on Neuralink and BCI research.*